论文部分内容阅读
为贯彻落实国家基本药物制度要求,强化基本药物监管,保证基本药物更好地服务广大基层群众,北京市食品药品监督管理局组织对我市基层医疗机构使用基本药物的不良反应开展专项监测,现将监测结果通报如下:一、监测数据情况本期监测范围依据《国家基本药物目录》(2012年版)和《北京市社区卫生服务药品(零差率)集中采购目录》确定,监测时段为2014年3月16日至2014年6月15日。
In order to implement the requirements of the national essential drug system, strengthen the supervision of essential medicines and ensure that essential medicines better serve the grassroots masses, the Beijing Food and Drug Administration organized special monitoring on the adverse reactions to the use of essential medicines in primary medical institutions in our city. The monitoring results are reported as follows: I. Monitoring Data The monitoring scope of this period is determined in accordance with the “Catalog of National Essential Medicines” (2012 version) and the Catalog of Centralized Procurement of Community Health Service Drugs (Zero Difference Rate) in Beijing with the monitoring period of 2014 From March 16 to June 15, 2014.